BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Cunningham CJ, Redondo-Castro E, Allan SM. The therapeutic potential of the mesenchymal stem cell secretome in ischaemic stroke. J Cereb Blood Flow Metab. 2018;38:1276-1292. [PMID: 29768965 DOI: 10.1177/0271678x18776802] [Cited by in Crossref: 124] [Cited by in F6Publishing: 134] [Article Influence: 24.8] [Reference Citation Analysis]
Number Citing Articles
1 Zhou H, He Y, Xiong W, Jing S, Duan X, Huang Z, Nahal GS, Peng Y, Li M, Zhu Y, Ye Q. MSC based gene delivery methods and strategies improve the therapeutic efficacy of neurological diseases. Bioactive Materials 2023;23:409-437. [DOI: 10.1016/j.bioactmat.2022.11.007] [Reference Citation Analysis]
2 Zhang Q, Shi S, Tang Y, Qu C, Wen S, Pan Y. Manf Enhances the Pyroptosis Inhibition of Bone Marrow-derived Mesenchymal Stem Cells to Relieve Cerebral Infarction Injury. Neuroscience 2023;510:109-28. [PMID: 36529294 DOI: 10.1016/j.neuroscience.2022.11.002] [Reference Citation Analysis]
3 Kaur H, Sarmah D, Datta A, Borah A, Yavagal DR, Bhattacharya P. Stem cells alleviate OGD/R mediated stress response in PC12 cells following a co-culture: modulation of the apoptotic cascade through BDNF-TrkB signaling. Cell Stress Chaperones 2023. [PMID: 36622548 DOI: 10.1007/s12192-022-01319-4] [Reference Citation Analysis]
4 Khodayar MJ, Rezaei Tazangi F, Samimi A, Alidadi H. Adipose-Derived Mesenchymal Stem Cells Secretome Induces Apoptosis in Colon Carcinoma HT-29 Cells. Jentashapir J Cell Mol Biol 2023;13. [DOI: 10.5812/jjcmb-133934] [Reference Citation Analysis]
5 Semita IN, Utomo DN, Suroto H, Sudiana IK, Gandi P. The mechanism of human neural stem cell secretomes improves neuropathic pain and locomotor function in spinal cord injury rat models: through antioxidant, anti-inflammatory, anti-matrix degradation, and neurotrophic activities. Korean J Pain 2023;36:72-83. [PMID: 36549874 DOI: 10.3344/kjp.22279] [Reference Citation Analysis]
6 Behzadifard M, Aboutaleb N, Dolatshahi M, Khorramizadeh M, Mirshekari Jahangiri H, Kord Z, Nazarinia D. Neuroprotective Effects of Conditioned Medium of Mesenchymal Stem Cells (MSC-CM) as a Therapy for Ischemic Stroke Recovery: A Systematic Review. Neurochem Res 2022. [PMID: 36581731 DOI: 10.1007/s11064-022-03848-x] [Reference Citation Analysis]
7 Liu P, Xie XR, Wu H, Li H, Chi JS, Liu XM, Luo J, Tang Y, Xu CX. Mesenchymal Stem Cells Promote Intestinal Mucosal Repair by Positively Regulating the Nrf2/Keap1/ARE Signaling Pathway in Acute Experimental Colitis. Dig Dis Sci 2022. [PMID: 36459293 DOI: 10.1007/s10620-022-07722-2] [Reference Citation Analysis]
8 Shieh JS, Chin YT, Chiu HC, Hsieh YY, Cheng HR, Gu H, Chang FW. Bio-Pulsed Stimulation Effectively Improves the Production of Avian Mesenchymal Stem Cell-Derived Extracellular Vesicles That Enhance the Bioactivity of Skin Fibroblasts and Hair Follicle Cells. Int J Mol Sci 2022;23. [PMID: 36499339 DOI: 10.3390/ijms232315010] [Reference Citation Analysis]
9 Wong R, Smith C, Allan S, Pinteaux E. Preconditioning with interleukin-1 alpha is required for the neuroprotective properties of mesenchymal stem cells after ischaemic stroke in mice.. [DOI: 10.21203/rs.3.rs-2263310/v1] [Reference Citation Analysis]
10 Quintanilla ME, Quezada M, Morales P, Berríos-cárcamo P, Santapau D, Ezquer M, Herrera-marschitz M, Israel Y, Ezquer F. Effect of human mesenchymal stem cell secretome administration on morphine self-administration and relapse in two animal models of opioid dependence. Transl Psychiatry 2022;12:462. [DOI: 10.1038/s41398-022-02225-0] [Reference Citation Analysis]
11 Huang Y, Zhu M, Liu Z, Hu R, Li F, Song Y, Geng Y, Ma W, Song K, Zhang M. Bone marrow mesenchymal stem cells in premature ovarian failure: Mechanisms and prospects. Front Immunol 2022;13:997808. [PMID: 36389844 DOI: 10.3389/fimmu.2022.997808] [Reference Citation Analysis]
12 Molloy EJ, El-Dib M, Juul SE, Benders M, Gonzalez F, Bearer C, Wu YW, Robertson NJ, Hurley T, Branagan A, Michael Cotten C, Tan S, Laptook A, Austin T, Mohammad K, Rogers E, Luyt K, Bonifacio S, Soul JS, Gunn AJ; Newborn Brain Society Guidelines and Publications Committee. Neuroprotective therapies in the NICU in term infants: present and future. Pediatr Res 2022. [PMID: 36195634 DOI: 10.1038/s41390-022-02295-2] [Reference Citation Analysis]
13 Yang LY, Chen YR, Lee JE, Chen KW, Luh HT, Chen YT, Wang KC, Hsieh ST. Dental Pulp Stem Cell-Derived Conditioned Medium Alleviates Subarachnoid Hemorrhage-Induced Microcirculation Impairment by Promoting M2 Microglia Polarization and Reducing Astrocyte Swelling. Transl Stroke Res 2022. [PMID: 36181630 DOI: 10.1007/s12975-022-01083-8] [Reference Citation Analysis]
14 Chu Y, Zuo J, Zhang Y, Gao G, Hu X, Han R, Liu C, Zhou H, Li M, Peng W, Wang Y. Co-culture with chorionic villous mesenchymal stem cells promotes endothelial cell proliferation and angiogenesis via ABCA9-AKT pathway. FASEB J 2022;36:e22568. [PMID: 36165221 DOI: 10.1096/fj.202101316RR] [Reference Citation Analysis]
15 Zhang S, Tuk B, van de Peppel J, Kremers GJ, Koedam M, Pesch GR, Rahman Z, Hoogenboezem RM, Bindels EMJ, van Neck JW, Boukany PE, van Leeuwen JPTM, van der Eerden BCJ. Microfluidic evidence of synergistic effects between mesenchymal stromal cell-derived biochemical factors and biomechanical forces to control endothelial cell function. Acta Biomater 2022:S1742-7061(22)00500-1. [PMID: 35995408 DOI: 10.1016/j.actbio.2022.08.025] [Reference Citation Analysis]
16 Tsuji M, Mukai T, Sato Y, Azuma Y, Yamamoto S, Cayetanot F, Bodineau L, Onoda A, Nagamura-inoue T, Coq J. Umbilical cord-derived mesenchymal stromal cell therapy to prevent the development of neurodevelopmental disorders related to low birth weight.. [DOI: 10.21203/rs.3.rs-1908880/v1] [Reference Citation Analysis]
17 Asgari Taei A, Khodabakhsh P, Nasoohi S, Farahmandfar M, Dargahi L. Paracrine Effects of Mesenchymal Stem Cells in Ischemic Stroke: Opportunities and Challenges. Mol Neurobiol 2022. [PMID: 35922728 DOI: 10.1007/s12035-022-02967-4] [Reference Citation Analysis]
18 Tan MI, Alfarafisa NM, Septiani P, Barlian A, Firmansyah M, Faizal A, Melani L, Nugrahapraja H. Potential Cell-Based and Cell-Free Therapy for Patients with COVID-19. Cells 2022;11:2319. [DOI: 10.3390/cells11152319] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Shekatkar MR, Kheur SM, Kharat AH, Deshpande SS, Sanap AP, Kheur MG, Bhonde RR. Assessment of angiogenic potential of mesenchymal stem cells derived conditioned medium from various oral sources. J Clin Transl Res 2022;8:323-38. [PMID: 36090765] [Reference Citation Analysis]
20 Kazemi Arababadi M, Rahmani MR, Asadi F, Shabanizadeh A, Yousefi-Ahmadipour A. Involvement of T-bet and GATA3 transcription factors in Mesenchymal stem cells and royal jelly combination treatment in brain stroke. J Stroke Cerebrovasc Dis 2022;31:106678. [PMID: 35882098 DOI: 10.1016/j.jstrokecerebrovasdis.2022.106678] [Reference Citation Analysis]
21 Kim YE, Ahn SY, Park WS, Sung DK, Sung SI, Yang MS, Chang YS. Mesenchymal-Stem-Cell-Derived Extracellular Vesicles Attenuate Brain Injury in Escherichia coli Meningitis in Newborn Rats. Life (Basel) 2022;12:1030. [PMID: 35888118 DOI: 10.3390/life12071030] [Reference Citation Analysis]
22 Skibber MA, Olson SD, Prabhakara KS, Gill BS, Cox CS. Enhancing Mesenchymal Stromal Cell Potency: Inflammatory Licensing via Mechanotransduction. Front Immunol 2022;13:874698. [DOI: 10.3389/fimmu.2022.874698] [Reference Citation Analysis]
23 Khosravi-Farsani S, Zaminy A, Kazemi S, Hashemzadeh-Chaleshtori M. Mesenchymal stem cells versus their conditioned medium in the treatment of ischemia/reperfusion injury: Evaluation of efficacy and hepatic specific gene expression in mice. Iran J Basic Med Sci 2022;25:799-807. [PMID: 36033951 DOI: 10.22038/IJBMS.2022.62642.13860] [Reference Citation Analysis]
24 Ren Y, Ailierken A, Zhao L, Lin Z, Jiang J, Li B, Wang J, Hua J, Tu Q. hUC-MSCs lyophilized powder loaded polysaccharide ulvan driven functional hydrogel for chronic diabetic wound healing. Carbohydrate Polymers 2022;288:119404. [DOI: 10.1016/j.carbpol.2022.119404] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
25 Asgari Taei A, Dargahi L, Khodabakhsh P, Kadivar M, Farahmandfar M. Hippocampal neuroprotection mediated by secretome of human mesenchymal stem cells against experimental stroke. CNS Neurosci Ther 2022. [PMID: 35715988 DOI: 10.1111/cns.13886] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
26 Calzetta L, Aiello M, Frizzelli A, Camardelli F, Cazzola M, Rogliani P, Chetta A. Stem Cell-Based Regenerative Therapy and Derived Products in COPD: A Systematic Review and Meta-Analysis. Cells 2022;11:1797. [PMID: 35681492 DOI: 10.3390/cells11111797] [Reference Citation Analysis]
27 Jingli Y, Jing W, Saeed Y, Widera D. Ischemic Brain Stroke and Mesenchymal Stem Cells: An Overview of Molecular Mechanisms and Therapeutic Potential. Stem Cells International 2022;2022:1-15. [DOI: 10.1155/2022/5930244] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
28 Chouw A, Sartika CR, Milanda T, Faried A. Effect of Type 2 Diabetes Mellitus Patient’s Serum as Preconditioning on Umbilical Cord Mesenchymal–Derived Secretome Production. Regen Eng Transl Med . [DOI: 10.1007/s40883-022-00259-w] [Reference Citation Analysis]
29 Ladeira BMF, Gomes MC, Custódio CA, Mano JF. High-Throughput Production of Microsponges from Platelet Lysate for Tissue Engineering Applications. Tissue Eng Part C Methods 2022. [PMID: 35343236 DOI: 10.1089/ten.TEC.2022.0029] [Reference Citation Analysis]
30 Shokravi S, Borisov V, Zaman BA, Niazvand F, Hazrati R, Khah MM, Thangavelu L, Marzban S, Sohrabi A, Zamani A. Mesenchymal stromal cells (MSCs) and their exosome in acute liver failure (ALF): a comprehensive review. Stem Cell Res Ther 2022;13:192. [PMID: 35527304 DOI: 10.1186/s13287-022-02825-z] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
31 Brovkina AS, Ushakov RE, Vassilieva IO, Domnina AP, Burova EB. Involvement of the PI3K/Akt/mTOR Pathway in Controlling Chondrogenic Differentiation of Endometrial Mesenchymal Stromal Cells. Cell Tiss Biol 2022;16:130-139. [DOI: 10.1134/s1990519x22020031] [Reference Citation Analysis]
32 Brooks B, Ebedes D, Usmani A, Gonzales-portillo JV, Gonzales-portillo D, Borlongan CV. Mesenchymal Stromal Cells in Ischemic Brain Injury. Cells 2022;11:1013. [DOI: 10.3390/cells11061013] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
33 Reboussin É, Buffault J, Brignole-Baudouin F, Réaux-Le Goazigo A, Riancho L, Olmiere C, Sahel JA, Mélik Parsadaniantz S, Baudouin C. Evaluation of neuroprotective and immunomodulatory properties of mesenchymal stem cells in an ex vivo retinal explant model. J Neuroinflammation 2022;19:63. [PMID: 35236378 DOI: 10.1186/s12974-022-02418-w] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
34 Zito G, Miceli V, Carcione C, Busà R, Bulati M, Gallo A, Iannolo G, Pagano D, Conaldi PG. Human Amnion-Derived Mesenchymal Stromal/Stem Cells Pre-Conditioning Inhibits Inflammation and Apoptosis of Immune and Parenchymal Cells in an In Vitro Model of Liver Ischemia/Reperfusion. Cells 2022;11:709. [DOI: 10.3390/cells11040709] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
35 Alvites R, Branquinho M, Sousa AC, Lopes B, Sousa P, Maurício AC. Mesenchymal Stem/Stromal Cells and Their Paracrine Activity—Immunomodulation Mechanisms and How to Influence the Therapeutic Potential. Pharmaceutics 2022;14:381. [DOI: 10.3390/pharmaceutics14020381] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 8.0] [Reference Citation Analysis]
36 Chouw A, Facicilia G, Sartika CR, Faried A, Milanda T. Factors Influencing the Therapeutic Potential of the MSC-derived Secretome. Regen Eng Transl Med . [DOI: 10.1007/s40883-021-00242-x] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
37 Bang OY, Kim EH, Moon GJ, Cha JM. Mesenchymal Stem Cell-Extracellular Vesicle Therapy in Patients with Stroke. Handbook of Stem Cell Therapy 2022. [DOI: 10.1007/978-981-16-6016-0_45-1] [Reference Citation Analysis]
38 Bang OY, Kim EH, Moon GJ, Cha JM. Mesenchymal Stem Cell-Extracellular Vesicle Therapy in Patients with Stroke. Handbook of Stem Cell Therapy 2022. [DOI: 10.1007/978-981-19-2655-6_45] [Reference Citation Analysis]
39 Warnecke A, Harre J, Shew M, Mellott AJ, Majewski I, Durisin M, Staecker H. Successful Treatment of Noise-Induced Hearing Loss by Mesenchymal Stromal Cells: An RNAseq Analysis of Protective/Repair Pathways. Front Cell Neurosci 2021;15:656930. [PMID: 34887728 DOI: 10.3389/fncel.2021.656930] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
40 Marofi F, Alexandrovna KI, Margiana R, Bahramali M, Suksatan W, Abdelbasset WK, Chupradit S, Nasimi M, Maashi MS. MSCs and their exosomes: a rapidly evolving approach in the context of cutaneous wounds therapy. Stem Cell Res Ther 2021;12:597. [PMID: 34863308 DOI: 10.1186/s13287-021-02662-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
41 Li G, Liu J, Guan Y, Ji X. The role of hypoxia in stem cell regulation of the central nervous system: From embryonic development to adult proliferation. CNS Neurosci Ther 2021;27:1446-57. [PMID: 34817133 DOI: 10.1111/cns.13754] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
42 Gong P, Zhang W, He Y, Wang J, Li S, Chen S, Ye Q, Li M. Classification and Characteristics of Mesenchymal Stem Cells and Its Potential Therapeutic Mechanisms and Applications against Ischemic Stroke. Stem Cells Int 2021;2021:2602871. [PMID: 34795764 DOI: 10.1155/2021/2602871] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
43 Hendow EK, Day RM. A facile approach to therapeutic angiogenesis using a platelet concentrate and microsphere composite. Nano Select. [DOI: 10.1002/nano.202100273] [Reference Citation Analysis]
44 Merkhan MM, Shephard MT, Forsyth NR. Physoxia alters human mesenchymal stem cell secretome. J Tissue Eng 2021;12:20417314211056132. [PMID: 34733464 DOI: 10.1177/20417314211056132] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
45 Hurd MD, Goel I, Sakai Y, Teramura Y. Current status of ischemic stroke treatment: From thrombolysis to potential regenerative medicine. Regen Ther 2021;18:408-17. [PMID: 34722837 DOI: 10.1016/j.reth.2021.09.009] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
46 Yu Q, Liao M, Sun C, Zhang Q, Deng W, Cao X, Wang Q, Omari-Siaw E, Bi S, Zhang Z, Yu J, Xu X. LBO-EMSC Hydrogel Serves a Dual Function in Spinal Cord Injury Restoration via the PI3K-Akt-mTOR Pathway. ACS Appl Mater Interfaces 2021;13:48365-77. [PMID: 34633177 DOI: 10.1021/acsami.1c12013] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
47 Zhou L, Yao P, Jiang L, Wang Z, Ma X, Wen G, Yang J, Zhou B, Yu Q. Salidroside-pretreated mesenchymal stem cells contribute to neuroprotection in cerebral ischemic injury in vitro and in vivo. J Mol Histol 2021. [PMID: 34570327 DOI: 10.1007/s10735-021-10022-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
48 Li Y, Zhong W, Tang X. Strategies to Improve the Efficiency of Transplantation with Mesenchymal Stem Cells for the Treatment of Ischemic Stroke: A Review of Recent Progress. Stem Cells Int 2021;2021:9929128. [PMID: 34490053 DOI: 10.1155/2021/9929128] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
49 Foo JB, Looi QH, Chong PP, Hassan NH, Yeo GEC, Ng CY, Koh B, How CW, Lee SH, Law JX. Comparing the Therapeutic Potential of Stem Cells and their Secretory Products in Regenerative Medicine. Stem Cells Int 2021;2021:2616807. [PMID: 34422061 DOI: 10.1155/2021/2616807] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
50 Moon S, Chang MS, Koh SH, Choi YK. Repair Mechanisms of the Neurovascular Unit after Ischemic Stroke with a Focus on VEGF. Int J Mol Sci 2021;22:8543. [PMID: 34445248 DOI: 10.3390/ijms22168543] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 7.0] [Reference Citation Analysis]
51 Hade MD, Suire CN, Suo Z. Mesenchymal Stem Cell-Derived Exosomes: Applications in Regenerative Medicine. Cells 2021;10:1959. [PMID: 34440728 DOI: 10.3390/cells10081959] [Cited by in Crossref: 31] [Cited by in F6Publishing: 39] [Article Influence: 15.5] [Reference Citation Analysis]
52 Rahimi B, Panahi M, Saraygord-Afshari N, Taheri N, Bilici M, Jafari D, Alizadeh E. The secretome of mesenchymal stem cells and oxidative stress: challenges and opportunities in cell-free regenerative medicine. Mol Biol Rep 2021;48:5607-19. [PMID: 34191238 DOI: 10.1007/s11033-021-06360-7] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
53 Manjua AC, Cabral JMS, Portugal CAM, Ferreira FC. Magnetic stimulation of the angiogenic potential of mesenchymal stromal cells in vascular tissue engineering. Sci Technol Adv Mater 2021;22:461-80. [PMID: 34248420 DOI: 10.1080/14686996.2021.1927834] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
54 Salikhova D, Bukharova T, Cherkashova E, Namestnikova D, Leonov G, Nikitina M, Gubskiy I, Akopyan G, Elchaninov A, Midiber K, Bulatenco N, Mokrousova V, Makarov A, Yarygin K, Chekhonin V, Mikhaleva L, Fatkhudinov T, Goldshtein D. Therapeutic Effects of hiPSC-Derived Glial and Neuronal Progenitor Cells-Conditioned Medium in Experimental Ischemic Stroke in Rats. Int J Mol Sci 2021;22:4694. [PMID: 33946667 DOI: 10.3390/ijms22094694] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
55 Bhandi S, Al Kahtani A, Mashyakhy M, Alsofi L, Maganur PC, Vishwanathaiah S, Testarelli L, Del Giudice A, Mehta D, Vyas N, Patil VR, Raj AT, Patil S. Modulation of the Dental Pulp Stem Cell Secretory Profile by Hypoxia Induction Using Cobalt Chloride. J Pers Med 2021;11:247. [PMID: 33808091 DOI: 10.3390/jpm11040247] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
56 Hayes CA, Valcarcel-Ares MN, Ashpole NM. Preclinical and clinical evidence of IGF-1 as a prognostic marker and acute intervention with ischemic stroke. J Cereb Blood Flow Metab 2021;41:2475-91. [PMID: 33757314 DOI: 10.1177/0271678X211000894] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
57 Kim Y. Emerging Treatment Options for Sarcopenia in Chronic Liver Disease. Life (Basel) 2021;11:250. [PMID: 33803020 DOI: 10.3390/life11030250] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
58 Naseroleslami M, Aboutaleb N. Human amniotic membrane mesenchymal stem cells exert cardioprotective effects against isoproterenol (ISO)-induced myocardial injury through suppression of inflammation and modulation of inflammatory MAPK/NF-κB pathway. Cell Tissue Bank 2021. [PMID: 33733423 DOI: 10.1007/s10561-021-09915-x] [Reference Citation Analysis]
59 Zhao N, Niu R, Zhu Y, Yu C. MRI tracking/detection of bone marrow mesenchymal stromal cells transplantation for treatment of ischemic cerebral infarction. Ibrain 2021;7:12-20. [DOI: 10.1002/j.2769-2795.2021.tb00059.x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
60 He J, Liu J, Huang Y, Tang X, Xiao H, Hu Z. Oxidative Stress, Inflammation, and Autophagy: Potential Targets of Mesenchymal Stem Cells-Based Therapies in Ischemic Stroke. Front Neurosci 2021;15:641157. [PMID: 33716657 DOI: 10.3389/fnins.2021.641157] [Cited by in Crossref: 25] [Cited by in F6Publishing: 29] [Article Influence: 12.5] [Reference Citation Analysis]
61 Li W, Shi L, Hu B, Hong Y, Zhang H, Li X, Zhang Y. Mesenchymal Stem Cell-Based Therapy for Stroke: Current Understanding and Challenges. Front Cell Neurosci 2021;15:628940. [PMID: 33633544 DOI: 10.3389/fncel.2021.628940] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 8.5] [Reference Citation Analysis]
62 Gan QF, Foo CN, Leong PP, Cheong SK. Incorporating regenerative medicine into rehabilitation programmes: a potential treatment for ankle sprain. International Journal of Therapy and Rehabilitation 2021;28:1-15. [DOI: 10.12968/ijtr.2019.0119] [Reference Citation Analysis]
63 Binch ALA, Fitzgerald JC, Growney EA, Barry F. Cell-based strategies for IVD repair: clinical progress and translational obstacles. Nat Rev Rheumatol 2021;17:158-75. [PMID: 33526926 DOI: 10.1038/s41584-020-00568-w] [Cited by in Crossref: 44] [Cited by in F6Publishing: 51] [Article Influence: 22.0] [Reference Citation Analysis]
64 Nagpal A, Milton AG, Koblar SA, Hamilton-Bruce MA. Clinical Translation of Cell Therapies in Stroke (CT2S) Checklist-a pragmatic tool to accelerate development of cell therapy products. Stem Cell Res Ther 2021;12:93. [PMID: 33514411 DOI: 10.1186/s13287-021-02147-6] [Reference Citation Analysis]
65 Miceli V, Bulati M, Iannolo G, Zito G, Gallo A, Conaldi PG. Therapeutic Properties of Mesenchymal Stromal/Stem Cells: The Need of Cell Priming for Cell-Free Therapies in Regenerative Medicine. Int J Mol Sci 2021;22:E763. [PMID: 33466583 DOI: 10.3390/ijms22020763] [Cited by in Crossref: 46] [Cited by in F6Publishing: 41] [Article Influence: 23.0] [Reference Citation Analysis]
66 Nammian P, Asadi-Yousefabad SL, Daneshi S, Sheikhha MH, Tabei SMB, Razban V. Comparative analysis of mouse bone marrow and adipose tissue mesenchymal stem cells for critical limb ischemia cell therapy. Stem Cell Res Ther 2021;12:58. [PMID: 33436054 DOI: 10.1186/s13287-020-02110-x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 7.5] [Reference Citation Analysis]
67 Bui TVA, Hwang JW, Lee JH, Park HJ, Ban K. Challenges and Limitations of Strategies to Promote Therapeutic Potential of Human Mesenchymal Stem Cells for Cell-Based Cardiac Repair. Korean Circ J 2021;51:97-113. [PMID: 33525065 DOI: 10.4070/kcj.2020.0518] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
68 González-González A, García-Sánchez D, Dotta M, Rodríguez-Rey JC, Pérez-Campo FM. Mesenchymal stem cells secretome: The cornerstone of cell-free regenerative medicine. World J Stem Cells 2020; 12(12): 1529-1552 [PMID: 33505599 DOI: 10.4252/wjsc.v12.i12.1529] [Cited by in Crossref: 36] [Cited by in F6Publishing: 34] [Article Influence: 12.0] [Reference Citation Analysis]
69 Wu MR, Lee CH, Hsiao JK. Bidirectional Enhancement of Cell Proliferation Between Iron Oxide Nanoparticle-Labeled Mesenchymal Stem Cells and Choroid Plexus in a Cell-Based Therapy Model of Ischemic Stroke. Int J Nanomedicine 2020;15:9181-95. [PMID: 33239875 DOI: 10.2147/IJN.S278687] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
70 Sommer CJ, Schäbitz WR. Principles and requirements for stroke recovery science. J Cereb Blood Flow Metab 2021;41:471-85. [PMID: 33175596 DOI: 10.1177/0271678X20970048] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
71 Kuang Y, Zheng X, Zhang L, Ai X, Venkataramani V, Kilic E, Hermann DM, Majid A, Bähr M, Doeppner TR. Adipose-derived mesenchymal stem cells reduce autophagy in stroke mice by extracellular vesicle transfer of miR-25. J Extracell Vesicles 2020;10:e12024. [PMID: 33304476 DOI: 10.1002/jev2.12024] [Cited by in Crossref: 40] [Cited by in F6Publishing: 45] [Article Influence: 13.3] [Reference Citation Analysis]
72 Jiang Y, Liu N, Han J, Li Y, Spencer P, Vodovoz SJ, Ning MM, Bix G, Katakam PVG, Dumont AS, Wang X. Diabetes Mellitus/Poststroke Hyperglycemia: a Detrimental Factor for tPA Thrombolytic Stroke Therapy. Transl Stroke Res 2021;12:416-27. [PMID: 33140258 DOI: 10.1007/s12975-020-00872-3] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 4.7] [Reference Citation Analysis]
73 Gramatiuk SM, Іvanova YV, Hudyma AA. Method of obtaining of nonneuronal cultures of astrocytes, derivated from human mesenchymal stem cells. KH 2020;87:68-73. [DOI: 10.26779/2522-1396.2020.9-10.68] [Reference Citation Analysis]
74 Vaes JEG, van Kammen CM, Trayford C, van der Toorn A, Ruhwedel T, Benders MJNL, Dijkhuizen RM, Möbius W, van Rijt SH, Nijboer CH. Intranasal mesenchymal stem cell therapy to boost myelination after encephalopathy of prematurity. Glia 2021;69:655-80. [PMID: 33045105 DOI: 10.1002/glia.23919] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
75 Prihatno SA, Adi YK, Budipitojo T. Immunolocalization of IL-6 and IL-10 in the testicular tissue of testicular dysfunction rat treated with secretome. J Adv Vet Anim Res 2020;7:514-20. [PMID: 33005678 DOI: 10.5455/javar.2020.g448] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
76 Yang H, Tian S, Xie L, Chen Y, Ma L. Intranasal administration of Cytoglobin modifies human umbilical cord‑derived mesenchymal stem cells and improves hypoxic‑ischemia brain damage in neonatal rats by modulating p38 MAPK signaling‑mediated apoptosis. Mol Med Rep 2020;22:3493-503. [PMID: 32945464 DOI: 10.3892/mmr.2020.11436] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
77 Ahmad F. Inflammatory response of stem cell secreting conditioned media in SH-SY5Y cell line. RB 2020;5:1243-1245. [DOI: 10.21931/rb/2020.05.03.13] [Reference Citation Analysis]
78 Li J, Zhang Q, Wang W, Lin F, Wang S, Zhao J. Mesenchymal stem cell therapy for ischemic stroke: A look into treatment mechanism and therapeutic potential. J Neurol. [DOI: 10.1007/s00415-020-10138-5] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 6.3] [Reference Citation Analysis]
79 Kitase Y, Sato Y, Arai S, Onoda A, Ueda K, Go S, Mimatsu H, Jabary M, Suzuki T, Ito M, Saito A, Hirakawa A, Mukai T, Nagamura-Inoue T, Takahashi Y, Tsuji M, Hayakawa M. Establishment of a Novel Fetal Growth Restriction Model and Development of a Stem-Cell Therapy Using Umbilical Cord-Derived Mesenchymal Stromal Cells. Front Cell Neurosci 2020;14:212. [PMID: 32848614 DOI: 10.3389/fncel.2020.00212] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
80 Tutuianu R, Rosca AM, Albu Kaya MG, Pruna V, Neagu TP, Lascar I, Simionescu M, Titorencu I. Mesenchymal stromal cell-derived factors promote the colonization of collagen 3D scaffolds with human skin cells. J Cell Mol Med 2020;24:9692-704. [PMID: 32666712 DOI: 10.1111/jcmm.15507] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
81 Oktaviono YH, Hutomo SA, Al-Farabi MJ, Chouw A, Sandra F. Human umbilical cord blood-mesenchymal stem cell-derived secretome in combination with atorvastatin enhances endothelial progenitor cells proliferation and migration. F1000Res 2020;9:537. [PMID: 34394921 DOI: 10.12688/f1000research.23547.2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
82 Oktaviono YH, Hutomo SA, Al-Farabi MJ, Chouw A, Sandra F. Human umbilical cord blood-mesenchymal stem cell-derived secretome in combination with atorvastatin enhances endothelial progenitor cells proliferation and migration. F1000Res 2020;9:537. [PMID: 34394921 DOI: 10.12688/f1000research.23547.2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
83 Sun Z, Gu L, Wu K, Wang K, Ru J, Yang S, Wang Z, Zhuge Q, Huang L, Huang S. VX-765 enhances autophagy of human umbilical cord mesenchymal stem cells against stroke-induced apoptosis and inflammatory responses via AMPK/mTOR signaling pathway. CNS Neurosci Ther 2020;26:952-61. [PMID: 32459063 DOI: 10.1111/cns.13400] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 4.3] [Reference Citation Analysis]
84 Nucci MP, Filgueiras IS, Ferreira JM, de Oliveira FA, Nucci LP, Mamani JB, Rego GNA, Gamarra LF. Stem cell homing, tracking and therapeutic efficiency evaluation for stroke treatment using nanoparticles: A systematic review. World J Stem Cells 2020; 12(5): 381-405 [PMID: 32547686 DOI: 10.4252/wjsc.v12.i5.381] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
85 Shi L, Rocha M, Zhang W, Jiang M, Li S, Ye Q, Hassan SH, Liu L, Adair MN, Xu J, Luo J, Hu X, Wechsler LR, Chen J, Shi Y. Genome-wide transcriptomic analysis of microglia reveals impaired responses in aged mice after cerebral ischemia. J Cereb Blood Flow Metab 2020;40:S49-66. [PMID: 32438860 DOI: 10.1177/0271678X20925655] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 8.3] [Reference Citation Analysis]
86 Barreca MM, Cancemi P, Geraci F. Mesenchymal and Induced Pluripotent Stem Cells-Derived Extracellular Vesicles: The New Frontier for Regenerative Medicine? Cells 2020;9:E1163. [PMID: 32397132 DOI: 10.3390/cells9051163] [Cited by in Crossref: 29] [Cited by in F6Publishing: 31] [Article Influence: 9.7] [Reference Citation Analysis]
87 Bonsack B, Corey S, Shear A, Heyck M, Cozene B, Sadanandan N, Zhang H, Gonzales-Portillo B, Sheyner M, Borlongan CV. Mesenchymal stem cell therapy alleviates the neuroinflammation associated with acquired brain injury. CNS Neurosci Ther 2020;26:603-15. [PMID: 32356605 DOI: 10.1111/cns.13378] [Cited by in Crossref: 33] [Cited by in F6Publishing: 34] [Article Influence: 11.0] [Reference Citation Analysis]
88 Lo JH, U KP, Yiu T, Ong MT, Lee WY. Sarcopenia: Current treatments and new regenerative therapeutic approaches. J Orthop Translat 2020;23:38-52. [PMID: 32489859 DOI: 10.1016/j.jot.2020.04.002] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 6.7] [Reference Citation Analysis]
89 Sigmarsdóttir Þ, McGarrity S, Rolfsson Ó, Yurkovich JT, Sigurjónsson ÓE. Current Status and Future Prospects of Genome-Scale Metabolic Modeling to Optimize the Use of Mesenchymal Stem Cells in Regenerative Medicine. Front Bioeng Biotechnol 2020;8:239. [PMID: 32296688 DOI: 10.3389/fbioe.2020.00239] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
90 Maacha S, Sidahmed H, Jacob S, Gentilcore G, Calzone R, Grivel JC, Cugno C. Paracrine Mechanisms of Mesenchymal Stromal Cells in Angiogenesis. Stem Cells Int 2020;2020:4356359. [PMID: 32215017 DOI: 10.1155/2020/4356359] [Cited by in Crossref: 82] [Cited by in F6Publishing: 92] [Article Influence: 27.3] [Reference Citation Analysis]
91 Lange-Consiglio A, Romele P, Magatti M, Silini A, Idda A, Martino NA, Cremonesi F, Parolini O. Priming with inflammatory cytokines is not a prerequisite to increase immune-suppressive effects and responsiveness of equine amniotic mesenchymal stromal cells. Stem Cell Res Ther 2020;11:99. [PMID: 32131892 DOI: 10.1186/s13287-020-01611-z] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
92 Cunningham CJ, Wong R, Barrington J, Tamburrano S, Pinteaux E, Allan SM. Systemic conditioned medium treatment from interleukin-1 primed mesenchymal stem cells promotes recovery after stroke. Stem Cell Res Ther. 2020;11:32. [PMID: 31964413 DOI: 10.1186/s13287-020-1560-y] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 5.0] [Reference Citation Analysis]
93 Vassilieva I, Kosheverova V, Vitte M, Kamentseva R, Shatrova A, Tsupkina N, Skvortsova E, Borodkina A, Tolkunova E, Nikolsky N, Burova E. Paracrine senescence of human endometrial mesenchymal stem cells: a role for the insulin-like growth factor binding protein 3. Aging (Albany NY) 2020;12:1987-2004. [PMID: 31951594 DOI: 10.18632/aging.102737] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
94 Mendes-pinheiro B, Marote A, Marques CR, Teixeira FG, Ribeiro JC, Salgado AJ. Applications of the stem cell secretome in regenerative medicine. Mesenchymal Stem Cells in Human Health and Diseases 2020. [DOI: 10.1016/b978-0-12-819713-4.00005-0] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
95 Binch ALA, Richardson SM, Hoyland JA, Barry FP. Combinatorial conditioning of adipose derived-mesenchymal stem cells enhances their neurovascular potential: Implications for intervertebral disc degeneration. JOR Spine 2019;2:e1072. [PMID: 31891121 DOI: 10.1002/jsp2.1072] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
96 Romanelli P, Bieler L, Scharler C, Pachler K, Kreutzer C, Zaunmair P, Jakubecova D, Mrowetz H, Benedetti B, Rivera FJ, Aigner L, Rohde E, Gimona M, Strunk D, Couillard-Despres S. Extracellular Vesicles Can Deliver Anti-inflammatory and Anti-scarring Activities of Mesenchymal Stromal Cells After Spinal Cord Injury. Front Neurol 2019;10:1225. [PMID: 31849808 DOI: 10.3389/fneur.2019.01225] [Cited by in Crossref: 39] [Cited by in F6Publishing: 40] [Article Influence: 9.8] [Reference Citation Analysis]
97 Surugiu R, Olaru A, Hermann DM, Glavan D, Catalin B, Popa-Wagner A. Recent Advances in Mono- and Combined Stem Cell Therapies of Stroke in Animal Models and Humans. Int J Mol Sci. 2019;20. [PMID: 31795466 DOI: 10.3390/ijms20236029] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 4.0] [Reference Citation Analysis]
98 Guo S, Som AT, Arai K, Lo EH. Effects of angiotensin-II on brain endothelial cell permeability via PPARalpha regulation of para- and trans-cellular pathways. Brain Res 2019;1722:146353. [PMID: 31356784 DOI: 10.1016/j.brainres.2019.146353] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 4.8] [Reference Citation Analysis]
99 Chudickova M, Vackova I, Machova Urdzikova L, Jancova P, Kekulova K, Rehorova M, Turnovcova K, Jendelova P, Kubinova S. The Effect of Wharton Jelly-Derived Mesenchymal Stromal Cells and Their Conditioned Media in the Treatment of a Rat Spinal Cord Injury. Int J Mol Sci 2019;20:E4516. [PMID: 31547264 DOI: 10.3390/ijms20184516] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 4.3] [Reference Citation Analysis]
100 Chan SJ, Niu W, Hayakawa K, Hamanaka G, Wang X, Cheah PS, Guo S, Yu Z, Arai K, Selim MH, Kurisawa M, Spector M, Lo EH. Promoting Neuro-Supportive Properties of Astrocytes with Epidermal Growth Factor Hydrogels. Stem Cells Transl Med 2019;8:1242-8. [PMID: 31483567 DOI: 10.1002/sctm.19-0159] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.8] [Reference Citation Analysis]
101 Zhu Z, Zheng L, Li Y, Huang T, Chao YC, Pan L, Zhu H, Zhao Y, Yu W, Li P. Potential Immunotherapeutic Targets on Myeloid Cells for Neurovascular Repair After Ischemic Stroke. Front Neurosci 2019;13:758. [PMID: 31447626 DOI: 10.3389/fnins.2019.00758] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
102 Kwon S, Yoo KH, Sym SJ, Khang D. Mesenchymal stem cell therapy assisted by nanotechnology: a possible combinational treatment for brain tumor and central nerve regeneration. Int J Nanomedicine 2019;14:5925-42. [PMID: 31534331 DOI: 10.2147/IJN.S217923] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 5.8] [Reference Citation Analysis]
103 Goodarzi P, Alavi-Moghadam S, Payab M, Larijani B, Rahim F, Gilany K, Bana N, Tayanloo-Beik A, Foroughi Heravani N, Hadavandkhani M, Arjmand B. Metabolomics Analysis of Mesenchymal Stem Cells. Int J Mol Cell Med 2019;8:30-40. [PMID: 32351907 DOI: 10.22088/IJMCM.BUMS.8.2.30] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
104 Maiti P, Peruzzaro S, Kolli N, Andrews M, Al-Gharaibeh A, Rossignol J, Dunbar GL. Transplantation of mesenchymal stem cells overexpressing interleukin-10 induces autophagy response and promotes neuroprotection in a rat model of TBI. J Cell Mol Med. 2019;23:5211-5224. [PMID: 31162801 DOI: 10.1111/jcmm.14396] [Cited by in Crossref: 25] [Cited by in F6Publishing: 28] [Article Influence: 6.3] [Reference Citation Analysis]
105 Harrell CR, Fellabaum C, Jovicic N, Djonov V, Arsenijevic N, Volarevic V. Molecular Mechanisms Responsible for Therapeutic Potential of Mesenchymal Stem Cell-Derived Secretome. Cells. 2019;8. [PMID: 31100966 DOI: 10.3390/cells8050467] [Cited by in Crossref: 186] [Cited by in F6Publishing: 197] [Article Influence: 46.5] [Reference Citation Analysis]
106 Nitkin CR, Rajasingh J, Pisano C, Besner GE, Thébaud B, Sampath V. Stem cell therapy for preventing neonatal diseases in the 21st century: Current understanding and challenges. Pediatr Res 2020;87:265-76. [PMID: 31086355 DOI: 10.1038/s41390-019-0425-5] [Cited by in Crossref: 28] [Cited by in F6Publishing: 30] [Article Influence: 7.0] [Reference Citation Analysis]
107 Yan X, Fu X, Jia Y, Ma X, Tao J, Yang T, Ma H, Liang X, Liu X, Yang J, Wei J. Nrf2/Keap1/ARE Signaling Mediated an Antioxidative Protection of Human Placental Mesenchymal Stem Cells of Fetal Origin in Alveolar Epithelial Cells. Oxid Med Cell Longev. 2019;2019:2654910. [PMID: 31217836 DOI: 10.1155/2019/2654910] [Cited by in Crossref: 20] [Cited by in F6Publishing: 27] [Article Influence: 5.0] [Reference Citation Analysis]
108 Vaes JEG, Vink MA, de Theije CGM, Hoebeek FE, Benders MJNL, Nijboer CHA. The Potential of Stem Cell Therapy to Repair White Matter Injury in Preterm Infants: Lessons Learned From Experimental Models. Front Physiol 2019;10:540. [PMID: 31143126 DOI: 10.3389/fphys.2019.00540] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 4.8] [Reference Citation Analysis]
109 Bang OY, Kim EH. Mesenchymal Stem Cell-Derived Extracellular Vesicle Therapy for Stroke: Challenges and Progress. Front Neurol. 2019;10:211. [PMID: 30915025 DOI: 10.3389/fneur.2019.00211] [Cited by in Crossref: 72] [Cited by in F6Publishing: 75] [Article Influence: 18.0] [Reference Citation Analysis]
110 Zhang Y, Yu S, Tuazon JP, Lee JY, Corey S, Kvederis L, Kingsbury C, Kaneko Y, Borlongan CV. Neuroprotective effects of human bone marrow mesenchymal stem cells against cerebral ischemia are mediated in part by an anti-apoptotic mechanism. Neural Regen Res 2019;14:597-604. [PMID: 30632499 DOI: 10.4103/1673-5374.247464] [Cited by in Crossref: 19] [Cited by in F6Publishing: 22] [Article Influence: 4.8] [Reference Citation Analysis]
111 Reza-Zaldivar EE, Hernández-Sapiéns MA, Gutiérrez-Mercado YK, Sandoval-Ávila S, Gomez-Pinedo U, Márquez-Aguirre AL, Vázquez-Méndez E, Padilla-Camberos E, Canales-Aguirre AA. Mesenchymal stem cell-derived exosomes promote neurogenesis and cognitive function recovery in a mouse model of Alzheimer's disease. Neural Regen Res 2019;14:1626-34. [PMID: 31089063 DOI: 10.4103/1673-5374.255978] [Cited by in Crossref: 70] [Cited by in F6Publishing: 75] [Article Influence: 17.5] [Reference Citation Analysis]
112 Baez-Jurado E, Guio-Vega G, Hidalgo-Lanussa O, González J, Echeverria V, Ashraf GM, Sahebkar A, Barreto GE. Mitochondrial Neuroglobin Is Necessary for Protection Induced by Conditioned Medium from Human Adipose-Derived Mesenchymal Stem Cells in Astrocytic Cells Subjected to Scratch and Metabolic Injury. Mol Neurobiol 2019;56:5167-87. [PMID: 30536184 DOI: 10.1007/s12035-018-1442-9] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
113 Vogel A, Upadhya R, Shetty AK. Neural stem cell derived extracellular vesicles: Attributes and prospects for treating neurodegenerative disorders. EBioMedicine 2018;38:273-82. [PMID: 30472088 DOI: 10.1016/j.ebiom.2018.11.026] [Cited by in Crossref: 76] [Cited by in F6Publishing: 79] [Article Influence: 15.2] [Reference Citation Analysis]
114 Wang X, Xuan W, Zhu ZY, Li Y, Zhu H, Zhu L, Fu DY, Yang LQ, Li PY, Yu WF. The evolving role of neuro-immune interaction in brain repair after cerebral ischemic stroke. CNS Neurosci Ther 2018;24:1100-14. [PMID: 30350341 DOI: 10.1111/cns.13077] [Cited by in Crossref: 50] [Cited by in F6Publishing: 54] [Article Influence: 10.0] [Reference Citation Analysis]
115 Puig B, Brenna S, Magnus T. Molecular Communication of a Dying Neuron in Stroke. Int J Mol Sci. 2018;19. [PMID: 30235837 DOI: 10.3390/ijms19092834] [Cited by in Crossref: 76] [Cited by in F6Publishing: 77] [Article Influence: 15.2] [Reference Citation Analysis]
116 Rajkovic O, Potjewyd G, Pinteaux E. Regenerative Medicine Therapies for Targeting Neuroinflammation After Stroke. Front Neurol 2018;9:734. [PMID: 30233484 DOI: 10.3389/fneur.2018.00734] [Cited by in Crossref: 34] [Cited by in F6Publishing: 36] [Article Influence: 6.8] [Reference Citation Analysis]
117 Orlovska IV, Yakovenko IO, Haidak AH, Zmejkoski DZ, Kozyrovska NO. Regenerative therapy for the nonhealing cutaneous wounds. Biopolym Cell 2018;34:171-195. [DOI: 10.7124/bc.000979] [Reference Citation Analysis]
118 Izadpanah M, Dargahi L, Ai J, Asgari Taei A, Ebrahimi Barough S, Mowla SJ, TavoosiDana G, Farahmandfar M. Extracellular Vesicles as a Neprilysin Delivery System Memory Improvement in Alzheimer's Disease. Iran J Pharm Res 2020;19:45-60. [PMID: 33224210 DOI: 10.22037/ijpr.2020.112062.13508] [Cited by in F6Publishing: 10] [Reference Citation Analysis]
119 Nasseri Maleki S, Aboutaleb N, Nazarinia D, Allahverdi Beik S, Qolamian A, Nobakht M. Conditioned medium obtained from human amniotic membrane-derived mesenchymal stem cell attenuates heart failure injury in rats. Iran J Basic Med Sci 2019;22:1253-8. [PMID: 32128088 DOI: 10.22038/ijbms.2019.36617.8722] [Cited by in F6Publishing: 6] [Reference Citation Analysis]